Drug Profile
Research programme: renin inhibitors 500 series - Roche/Speedel
Alternative Names: SPP 500Latest Information Update: 12 Oct 2007
Price :
$50
*
At a glance
- Originator Roche
- Developer Speedel Development
- Class
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 05 Apr 2006 This programme is still in active development - (BIO-Europe-2005)
- 11 May 2005 This programme is still in active development - (BioSquare-2005)
- 04 Apr 2002 Preclinical trials in Hypertension in Switzerland (unspecified route)